UNIVERSAL CORP quarterly report, Q1 FY2013

Universal Corporation — Q1 FY2014 Form 10-Q

Reporting period: Three months ended June 30, 2013; comparison is the three months ended June 30, 2012. The filing describes Universal as a global leaf tobacco merchant and processor and emphasizes that quarterly results are seasonal. The request metadata says 2012 Q1, but the filing itself covers Q1 FY2014.

Financial results

MetricQ1 FY2014Q1 FY2013
Sales and operating revenue$433.5 million$461.4 million
Operating income$86.5 million$42.8 million
Net income attributable to Universal$58.3 million$23.1 million
Diluted EPS$2.05$0.81
Operating cash flow$(233.0) million$(57.9) million
Capital expenditures$10.4 million$8.7 million
Common dividend declared per share$0.50$0.49

Reported earnings included an $81.6 million pretax gain ($53.1 million after tax, or $1.98 per diluted share) from a favorable Brazilian excise-tax-credit case. Excluding that unusual gain, attributable net income was approximately $5.2 million and diluted EPS approximately $0.07; management said underlying net income declined $17.9 million year over year. Revenue fell 6%, reflecting lower shipment volumes, partly offset by higher average prices. The filing does not provide a clear consolidated operating margin excluding the gain; segment operating income was $6.4 million versus $44.2 million.

At June 30, 2013, cash was $124.5 million, total current assets $1.835 billion, and current liabilities $734.0 million. Notes payable and overdrafts were $133.1 million; long-term obligations were $177.5 million, with $212.5 million classified as current maturities. Management-defined net debt was $462.7 million, up $307.8 million from March 31, mainly due to seasonal working capital. Net debt was about 26% of net capitalization. The company had $450 million available under its committed revolving facility and approximately $301 million of unused uncommitted credit lines, and reported compliance with debt covenants.

Changes and operating drivers

  • Operating cash use increased by $175.1 million year over year, primarily because of seasonal working-capital needs. Tobacco inventory rose $454.7 million from March 31 to $1.078 billion; inventory was $115.7 million above the year-ago level.
  • Flue-cured and burley operations recorded a $2.8 million operating loss, compared with $35.8 million operating income. Other Regions fell to a $5.2 million loss, chiefly because prior-year results included substantial African carryover shipments and because of currency losses and South American margin pressure. North America improved to $2.4 million income; Other Tobacco Operations rose to $9.2 million.
  • SG&A increased $17.4 million, including $12.5 million from unfavorable currency remeasurement and exchange results versus gains in the prior year. Interest expense declined $0.9 million.
  • Uncommitted tobacco inventory was $79.4 million, or about 7% of tobacco inventory, below the company’s normal range. Most inventory was committed to customers.

Outlook, risks, and contingencies

  • Management expected a solid FY2014, but anticipated lower total shipment volumes than FY2013. Shipments were expected to increase as current South American and African crops ramped up in the second and third quarters; unusually low uncommitted inventory limited additional sales potential.
  • Management cited strong global demand, volatile Brazilian green-leaf prices and margin pressure, reduced burley crop expectations in some origins, and heavy rainfall affecting the U.S. crop. Crop size, shipment timing, currency movements, weather, regulation, and market conditions remain risks. No numerical earnings or revenue guidance was provided.
  • The Brazilian court decision granted approximately $104 million of tax credits, to be used against future federal taxes over up to five years. The company recorded a $90 million net credit balance after an allowance; realization depends on utilization and remains subject to tax-authority audit.
  • A €30 million European Commission antitrust fine plus interest remains under appeal. The company had recorded the liability and collateralized the bank guarantee with a $50 million deposit; it expected a decision during FY2014.
  • A Brazilian inter-state VAT assessment had been reduced to approximately $15 million and remained contested; no liability was recorded because a loss was not considered probable. Grower loan guarantees had a maximum potential payment of $4 million and expire within one year.
  • The company announced a new subsidiary venture to produce liquid nicotine for e-cigarettes with a botanical extraction company; it said the business was at an early stage and future results could not yet be predicted. No major capital expenditures were approved for the next 12 months.

Investor facts to verify

  • Separate recurring operating performance from the $81.6 million Brazilian tax-case gain, including its tax treatment and cash realization timetable.
  • Track seasonal working capital, inventory commitments, operating cash flow, and the availability and terms of credit facilities.
  • Monitor crop sizes, shipment volumes, green-leaf pricing, and currency effects, particularly in Africa, South America, and the United States.
  • Follow the European Commission appeal and Brazilian VAT assessment, along with the realization and audit status of the Brazilian tax credits.
  • Assess whether the new liquid-nicotine venture develops beyond its initial stage; the filing provides no earnings outlook for it.